Clinical Trial Update: Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of chemoembolization and stereotactic body radiation therapy for unresectable hepatocellular carcinoma has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Chemoembolization
• Stereotactic Body Radiation Therapy (SBRT)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-06-18